Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbvie Inc.filedCriticalAbbvie Inc.
Publication of HK1233205A1publicationCriticalpatent/HK1233205A1/en
The invention relates to anti-epidermal growth factor (EGFR) antibodies and antibody drug conjugates (ADCs), including compositions and methods of using said antibodies and ADCs.
HK17106747.4A2014-03-212015-03-20Anti-egfr antibodies and antibody drug conjugates
HK1233205A1
(en)